Map: Diabetes spending per patient varies almost threefold between CCGs

Spending on diabetes treatment per patient with the condition varies almost threefold between CCGs in England, official data reveal.

Diabetes (Photo: Tom Merton/Getty Images)
Diabetes (Photo: Tom Merton/Getty Images)

Total spending on diabetes prescribing in England hit £1.07bn in 2018/19 - one pound in every eight spent on prescribing in primary care, according to figures published by NHS Digital.

The proportion of primary care prescribing costs that relate to diabetes has climbed sharply over the past decade, from just 7% in 2008/9 to 12.5% in 2018/9.

This rapid rise in the proportion of primary care prescribing spending consumed by diabetes treatments reflects the fact that while total spending on primary care prescribing has risen just 6% over the past decade, diabetes prescribing costs have risen by a staggering 79%.

Antidiabetic drugs

Much of the rise has been driven by a sharp increase in spending on antidiabetic drugs, which totalled £540m in 2018/19 - half of total diabetes prescribing costs in primary care. A decade earlier antidiabetic drug costs accounted for just over a quarter of total diabetes prescribing costs in primary care.

Diabetes prescribing per patient with diabetes cost £327.78 on average across England in 2018/19 - but variation between CCG areas is significant.

In NHS Kernow CCG, the highest-spending area, diabetes prescribing cost £587.12 per patient with diabetes in 2018/19. This is almost three times the amount spent per patient in NHS Northumberland CCG - where the average for 2018/19 was £208.07.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Vaccination tracker

UK COVID-19 vaccination programme tracker

GPs across the UK have led the largest-ever NHS vaccination programme in response...

RCGP chair Professor Martin Marshall

Hand PCNs control of primary care infrastructure funding, says RCGP

CCG funding for primary care infrastructure should be handed to PCNs when the bodies...

Professor Martin Marshall and Talking General Practice logo

Podcast: RCGP chair Professor Martin Marshall

Talking General Practice speaks to RCGP chair Professor Martin Marshall.

Dr Chaand Nagpaul

In-house review not enough to stop 'unjust' GMC referrals, warns BMA

Doctors' leaders have repeated calls for a full independent review of the GMC referral...


How widespread is long COVID in the UK?

Millions of people in the UK are living with long COVID. GPonline looks at the data...

COVID-19 vaccination sign

GP contract for autumn COVID-19 booster campaign due shortly

GP practices in England will be invited shortly to sign up for the COVID-19 autumn...